Professional Role and Responsibilities
Heather Shannon Grant currently serves as an Administrative Business Partner at Parabilis Medicines (formerly FogPharma), a clinical-stage biotechnology company specializing in the development of peptide therapeutics within the pharmaceutical industry. Her role involves expertise in administrative and project management functions, supporting operational and strategic initiatives within the company. She is based in the Greater Boston area and maintains a professional network of over 500 LinkedIn connections, indicating strong industry engagement and networking capability.
Educational Background
Heather Grant holds a degree from the University of Massachusetts, Amherst, which underpins her foundational knowledge and professional development relevant to her administrative and operational roles in the biotech sector.
Company Overview: Parabilis Medicines
Parabilis Medicines, rebranded from FogPharma, focuses on developing novel Helicon™ peptide therapeutics with an emphasis on oncology and other therapeutic areas. The company is actively advancing its clinical pipeline, notably the ongoing Phase 1/2 study of FOG-001, a β-catenin TCF4 inhibitor, signifying a strong commitment to groundbreaking cancer drug research. Recent financing milestones highlight the company’s robust financial backing:
- $66 million Series B financing completed, led by 6 Dimensions Capital.
- $145 million Series E funding round led by General Catalyst, underscoring investor confidence in Parabilis’s technology and clinical programs.
Parabilis is positioning itself at the forefront of integrating artificial intelligence (AI) and physics-based discovery platforms to accelerate drug development, as highlighted by the company's recent rebranding announcement.
Industry Position and Strategic Insights
Parabilis Medicines has rapidly become a notable player in peptide therapeutics innovation, supported by significant capital raises totaling over $178 million across multiple funding rounds in recent years. The company’s focus on AI-enabled drug discovery, combined with its advancement of a diverse clinical pipeline—including ERG degrader programs targeting prostate cancers—reflects strategic expansion in oncology therapeutics.
As an Administrative Business Partner, Heather Grant likely plays a key role in supporting senior leadership and cross-functional teams to enable efficient project execution and strategic alignment with these high-growth, cutting-edge research initiatives.
Geographic and Network Context
Located in Greater Boston, a major biotechnology hub, Heather Grant operates in a highly competitive and innovation-driven environment, affording access to extensive industry resources and partnerships that facilitate Parabilis’s research and development objectives.
This profiling synthesizes Heather Shannon Grant’s professional administrative expertise within Parabilis Medicines’ context of rapid clinical and technological advancement, emphasizing organizational support critical to sustaining growth and innovation in a competitive biotechnology landscape.
